(Q36996241)
Statements
1 reference
Taxane vs. taxane: is the duel at an end? A commentary on a phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study (English)
1 reference
Sofyan M Radaideh
1 reference
George W Sledge
1 reference
8 November 2007
1 reference
1 reference
111
1 reference
2
1 reference
203-208
1 reference
1 reference
Identifiers
1 reference
1 reference